DOCSLIB.ORG

Mouse Ccny Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Ccny Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Ccny Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Ccny conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Ccny gene (NCBI Reference Sequence: NM_026484.3 ; Ensembl: ENSMUSG00000024286 ) is located on Mouse chromosome 18. 10 exons are identified, with the ATG start codon in exon 1 and the TAA stop codon in exon 10 (Transcript: ENSMUST00000053917). Exon 6~7 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Ccny gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-444I9 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a knock-out allele exhibit impaired adipogenesis and lipid production. Exon 6 starts from about 39.3% of the coding region. The knockout of Exon 6~7 will result in frameshift of the gene. The size of intron 5 for 5'-loxP site insertion: 3916 bp, and the size of intron 7 for 3'-loxP site insertion: 12243 bp. The size of effective cKO region: ~778 bp. The cKO region does not have any other known gene. Page 1 of 7 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 6 7 10 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Ccny Homology arm cKO region loxP site Page 2 of 7 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(7278bp) | A(27.64% 2012) | C(19.95% 1452) | T(31.92% 2323) | G(20.49% 1491) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 7 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr18 - 9345722 9348721 3000 browser details YourSeq 88 2033 2224 3000 88.0% chr9 + 61188981 61189187 207 browser details YourSeq 73 2074 2227 3000 93.0% chrX + 13753024 13753192 169 browser details YourSeq 72 2055 2224 3000 89.1% chr9 - 49561758 49561948 191 browser details YourSeq 72 2060 2207 3000 92.0% chr19 - 26360921 26361081 161 browser details YourSeq 66 2049 2202 3000 91.3% chr13 + 73045178 73045343 166 browser details YourSeq 64 2049 2224 3000 82.0% chr10 + 60627887 60628081 195 browser details YourSeq 59 2043 2224 3000 94.1% chrX - 161953890 161954080 191 browser details YourSeq 58 2052 2379 3000 91.5% chr14 + 9241590 9242899 1310 browser details YourSeq 49 2170 2270 3000 94.7% chr11 + 19635967 19636070 104 browser details YourSeq 47 2169 2225 3000 87.5% chr15 - 58812801 58812856 56 browser details YourSeq 45 2190 2271 3000 94.2% chr4 - 125935622 125935705 84 browser details YourSeq 45 2033 2104 3000 84.3% chr15 - 86505876 86505945 70 browser details YourSeq 44 2075 2194 3000 94.0% chr10 + 90538959 90539096 138 browser details YourSeq 43 2173 2227 3000 86.8% chr4 - 65199289 65199342 54 browser details YourSeq 41 2045 2093 3000 91.9% chr4 + 82840085 82840133 49 browser details YourSeq 40 2049 2103 3000 91.7% chr11 - 48523005 48523064 60 browser details YourSeq 40 21 144 3000 80.9% chr11 + 54976305 54976423 119 browser details YourSeq 40 2816 2995 3000 63.3% chr1 + 87987601 87987691 91 browser details YourSeq 39 2173 2227 3000 83.1% chr1 + 121148320 121148373 54 Note: The 3000 bp section upstream of Exon 6 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr18 - 9341944 9344943 3000 browser details YourSeq 1573 919 2962 3000 90.8% chr1 - 189467192 190023777 556586 browser details YourSeq 1475 962 2962 3000 89.2% chr15 - 36358270 36360324 2055 browser details YourSeq 1473 924 2962 3000 88.6% chr15 + 34626648 35249920 623273 browser details YourSeq 1455 927 2962 3000 88.9% chr10 - 40014410 40016434 2025 browser details YourSeq 1454 944 2962 3000 89.7% chr17 - 85423800 85425827 2028 browser details YourSeq 1444 908 2962 3000 88.7% chr17 - 94158862 94160906 2045 browser details YourSeq 1441 929 2962 3000 88.2% chr3 + 115056732 115058750 2019 browser details YourSeq 1438 913 2951 3000 89.2% chr1 + 161512696 161514735 2040 browser details YourSeq 1430 928 2962 3000 87.9% chr18 - 52704268 52706283 2016 browser details YourSeq 1398 922 2962 3000 87.1% chr9 - 34320183 34322173 1991 browser details YourSeq 1388 922 2962 3000 88.5% chr2 + 13618677 13620705 2029 browser details YourSeq 1381 978 2962 3000 87.7% chrX - 16865966 16867972 2007 browser details YourSeq 1378 922 2962 3000 87.7% chr1 - 92580071 92582039 1969 browser details YourSeq 1359 978 2963 3000 87.8% chrX - 155531838 155533843 2006 browser details YourSeq 1358 905 2917 3000 88.0% chr1 + 4171430 4173446 2017 browser details YourSeq 1357 1127 2962 3000 89.5% chr17 - 89193632 89195461 1830 browser details YourSeq 1349 923 2962 3000 88.9% chr17 + 56526839 56528967 2129 browser details YourSeq 1348 919 2944 3000 87.8% chr14 - 36382380 36384401 2022 browser details YourSeq 1338 922 2962 3000 87.9% chr8 + 105029576 105031540 1965 Note: The 3000 bp section downstream of Exon 7 is BLAT searched against the genome. No significant similarity is found. Page 4 of 7 https://www.alphaknockout.com Gene and protein information: Ccny cyclin Y [ Mus musculus (house mouse) ] Gene ID: 67974, updated on 26-Jun-2020 Gene summary Official Symbol Ccny provided by MGI Official Full Name cyclin Y provided by MGI Primary source MGI:MGI:1915224 See related Ensembl:ENSMUSG00000024286 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as 1700025H17Rik; 3110050L10Rik; 4631402G10Rik; 5730405I09Rik Expression Ubiquitous expression in adrenal adult (RPKM 25.9), ovary adult (RPKM 20.4) and 28 other tissues See more Orthologs human all Genomic context Location: 18; 18 A1 See Ccny in Genome Data Viewer Exon count: 13 Annotation release Status Assembly Chr Location 108.20200622 current GRCm38.p6 (GCF_000001635.26) 18 NC_000084.6 (9312304..9450154, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 18 NC_000084.5 (9314042..9450148, complement) Chromosome 18 - NC_000084.6 Page 5 of 7 https://www.alphaknockout.com Transcript information: This gene has 5 transcripts Gene: Ccny ENSMUSG00000024286 Description cyclin Y [Source:MGI Symbol;Acc:MGI:1915224] Gene Synonyms 1700025H17Rik, 3110050L10Rik, 4631402G10Rik, 5730405I09Rik Location Chromosome 18: 9,312,304-9,450,154 reverse strand. GRCm38:CM001011.2 About this gene This gene has 5 transcripts (splice variants), 114 orthologues, 1 paralogue, is a member of 1 Ensembl protein family and is associated with 19 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Ccny- ENSMUST00000053917.5 5757 341aa ENSMUSP00000050001.4 Protein coding CCDS29050 Q8BGU5 TSL:1 201 GENCODE basic APPRIS P1 Ccny- ENSMUST00000234102.1 2505 316aa ENSMUSP00000157340.1 Protein coding - Q8BGU5 GENCODE 202 basic Ccny- ENSMUST00000234844.1 1354 99aa ENSMUSP00000157086.1 Nonsense mediated - A0A3Q4EBW6 - 205 decay Ccny- ENSMUST00000234779.1 1341 26aa ENSMUSP00000157353.1 Nonsense mediated - A0A3Q4EIH7 CDS 5' 204 decay incomplete Ccny- ENSMUST00000234382.1 1046 No - Retained intron - - - 203 protein 157.85 kb Forward strand 9.32Mb 9.34Mb 9.36Mb 9.38Mb 9.40Mb 9.42Mb 9.44Mb 9.46Mb Genes Gm50053-201 >processed pseudogene (Comprehensive set... Contigs < AC161530.4 Genes (Comprehensive set... < Ccny-201protein coding < Ccny-202protein coding < Ccny-204nonsense mediated decay < Gm50055-201TEC < Ccny-205nonsense mediated decay < Ccny-203retained intron Regulatory Build 9.32Mb 9.34Mb 9.36Mb 9.38Mb 9.40Mb 9.42Mb 9.44Mb 9.46Mb Reverse strand 157.85 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Transcription Factor Binding Site Gene Legend Protein Coding merged Ensembl/Havana Ensembl protein coding Non-Protein Coding processed transcript pseudogene Page 6 of 7 https://www.alphaknockout.com Transcript: ENSMUST00000053917 < Ccny-201protein coding Reverse strand 137.85 kb ENSMUSP00000050... Low complexity (Seg) Superfamily Cyclin-like superfamily SMART Cyclin-like Pfam Cyclin, N-terminal PIRSF Cyclin Y PANTHER PTHR14248:SF33 PTHR14248 Gene3D 1.10.472.10 CDD Cyclin-like All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant synonymous variant Scale bar 0 40 80 120 160 200 240 280 341 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 7 of 7.
Load more

Recommended publications
  • Genome-Wide DNA Methylation Profiling Identifies Differential Methylation in Uninvolved Psoriatic Epidermis
    Genome-Wide DNA Methylation Profiling Identifies Differential Methylation in Uninvolved Psoriatic Epidermis Deepti Verma, Anna-Karin Ekman, Cecilia Bivik Eding and Charlotta Enerbäck The self-archived postprint version of this journal article is available at Linköping University Institutional Repository (DiVA): http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-147791 N.B.: When citing this work, cite the original publication. Verma, D., Ekman, A., Bivik Eding, C., Enerbäck, C., (2018), Genome-Wide DNA Methylation Profiling Identifies Differential Methylation in Uninvolved Psoriatic Epidermis, Journal of Investigative Dermatology, 138(5), 1088-1093. https://doi.org/10.1016/j.jid.2017.11.036 Original publication available at: https://doi.org/10.1016/j.jid.2017.11.036 Copyright: Elsevier http://www.elsevier.com/ Genome-Wide DNA Methylation Profiling Identifies Differential Methylation in Uninvolved Psoriatic Epidermis Deepti Verma*a, Anna-Karin Ekman*a, Cecilia Bivik Edinga and Charlotta Enerbäcka *Authors contributed equally aIngrid Asp Psoriasis Research Center, Department of Clinical and Experimental Medicine, Division of Dermatology, Linköping University, Linköping, Sweden Corresponding author: Charlotta Enerbäck Ingrid Asp Psoriasis Research Center, Department of Clinical and Experimental Medicine, Linköping University SE-581 85 Linköping, Sweden Phone: +46 10 103 7429 E-mail: [email protected] Short title Differential methylation in psoriasis Abbreviations CGI, CpG island; DMS, differentially methylated site; RRBS, reduced representation bisulphite sequencing Keywords (max 6) psoriasis, epidermis, methylation, Wnt, susceptibility, expression 1 ABSTRACT Psoriasis is a chronic inflammatory skin disease with both local and systemic components. Genome-wide approaches have identified more than 60 psoriasis-susceptibility loci, but genes are estimated to explain only one third of the heritability in psoriasis, suggesting additional, yet unidentified, sources of heritability.
    [Show full text]
  • Resumenedwidekoct13post.Pdf 89.9 KB
    Maria Nicole Nedwidek, Ph.D. Maria Nicole Nedwidek, Ph.D. E-mail: [email protected] web: http://d-ned.com EDUCATION City College of New York at the City University of New York New York, NY 10031 NYC Teaching Fellows: Master of Arts, Biology Science Education; GPA 3.97, w/honors: 6/2007. Harvard University School of Medicine - Massachusetts General Hospital Boston, MA 02114 Research Fellowship in Cancer Biology-Dept. of Medicine: appointed to faculty September, 1999. Princeton University Princeton, NJ 08544 Doctor of Philosophy degree in Molecular Biology awarded January, 1999. Princeton University Princeton, NJ 08544 Master of Arts degree in Molecular Biology awarded June, 1994. Massachusetts Institute of Technology Cambridge, MA 02139 Bachelor of Science degree in Biology awarded June, 1992. Grade Point Average: 4.4 out of 5.0 Stuyvesant High School New York, NY 10009 High School Diploma awarded June, 1988. Grade Point Average: 95.45% PUBLICATIONS AND PRESENTATIONS Nedwidek, M. N. and Hecht, M. H. (1997). Minimized protein structures: A little goes a long way. Proceedings of the National Academy of Sciences USA 94 (19), 10010-10011. Nedwidek, M. N. (1999). Rational Combinatorial Design Suggests an Evolutionary Approach for Building Proteins. Ph.D. Dissertation, Department of Molecular Biology, Princeton University, Princeton, NJ, 08544. Avruch, J. (presenter), Khokhlatchev, A., Nedwidek, M., Tzivion, G., Vavvas, D., Zhang, X-f. (2000) Ras Regulation of Protein Kinases. 25th European Symposium on Hormones and Cell Regulation: Protein Kinase Cascades in Signal Transduction; Nunez Lecture, September 2000, Alsace, France. web: http://www.dcb-glostrup.dk/kinase/symposium_2000/abstr_4.htm Ortiz-Vega, S., Khokhlatchev, A., Nedwidek, M., Zhang, X-f., Dammann, R., Pfeifer, G.P., and Avruch, J.
    [Show full text]
  • Single Cell Derived Clonal Analysis of Human Glioblastoma Links
    SUPPLEMENTARY INFORMATION: Single cell derived clonal analysis of human glioblastoma links functional and genomic heterogeneity ! Mona Meyer*, Jüri Reimand*, Xiaoyang Lan, Renee Head, Xueming Zhu, Michelle Kushida, Jane Bayani, Jessica C. Pressey, Anath Lionel, Ian D. Clarke, Michael Cusimano, Jeremy Squire, Stephen Scherer, Mark Bernstein, Melanie A. Woodin, Gary D. Bader**, and Peter B. Dirks**! ! * These authors contributed equally to this work.! ** Correspondence: [email protected] or [email protected]! ! Supplementary information - Meyer, Reimand et al. Supplementary methods" 4" Patient samples and fluorescence activated cell sorting (FACS)! 4! Differentiation! 4! Immunocytochemistry and EdU Imaging! 4! Proliferation! 5! Western blotting ! 5! Temozolomide treatment! 5! NCI drug library screen! 6! Orthotopic injections! 6! Immunohistochemistry on tumor sections! 6! Promoter methylation of MGMT! 6! Fluorescence in situ Hybridization (FISH)! 7! SNP6 microarray analysis and genome segmentation! 7! Calling copy number alterations! 8! Mapping altered genome segments to genes! 8! Recurrently altered genes with clonal variability! 9! Global analyses of copy number alterations! 9! Phylogenetic analysis of copy number alterations! 10! Microarray analysis! 10! Gene expression differences of TMZ resistant and sensitive clones of GBM-482! 10! Reverse transcription-PCR analyses! 11! Tumor subtype analysis of TMZ-sensitive and resistant clones! 11! Pathway analysis of gene expression in the TMZ-sensitive clone of GBM-482! 11! Supplementary figures and tables" 13" "2 Supplementary information - Meyer, Reimand et al. Table S1: Individual clones from all patient tumors are tumorigenic. ! 14! Fig. S1: clonal tumorigenicity.! 15! Fig. S2: clonal heterogeneity of EGFR and PTEN expression.! 20! Fig. S3: clonal heterogeneity of proliferation.! 21! Fig.
    [Show full text]
  • A Comparative Analysis of the Transcriptome Profiles of Liver and Muscle Tissue in Pigs Divergent for Feed Efficiency Stafford Vigors1, John V
    Vigors et al. BMC Genomics (2019) 20:461 https://doi.org/10.1186/s12864-019-5740-z RESEARCH ARTICLE Open Access A comparative analysis of the transcriptome profiles of liver and muscle tissue in pigs divergent for feed efficiency Stafford Vigors1, John V. O’Doherty2, Kenneth Bryan2 and Torres Sweeney1* Abstract Background: The improvement of feed efficiency is a key economic goal within the pig production industry. The objective of this study was to examine transcriptomic differences in both the liver and muscle of pigs divergent for feed efficiency, thus improving our understanding of the molecular mechanisms influencing feed efficiency and enabling the identification of candidate biomarkers. Residual feed intake (RFI) was calculated for two populations of pigs from two different farms of origin/genotype. The 6 most efficient (LRFI) and 6 least efficient (HRFI) animals from each population were selected for further analysis of Longissimus Dorsi muscle (n = 22) and liver (n = 23). Transcriptomic data were generated from liver and muscle collected post-slaughter. Results: The transcriptomic data segregated based on the RFI value of the pig rather than genotype/farm of origin. A total of 6463 genes were identified as being differentially expressed (DE) in muscle, while 964 genes were identified as being DE in liver. Genes that were commonly DE between muscle and liver (n = 526) were used for the multi-tissue analysis. These 526 genes were associated with protein targeting to membrane, extracellular matrix organisation and immune function. In the muscle-only analysis, genes associated with RNA processing, protein synthesis and energy metabolism were down regulated in the LRFI animals while in the liver-only analysis, genes associated with cell signalling and lipid homeostasis were up regulated in the LRFI animals.
    [Show full text]
  • WO 2016/040794 Al 17 March 2016 (17.03.2016) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2016/040794 Al 17 March 2016 (17.03.2016) P O P C T (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, C12N 1/19 (2006.01) C12Q 1/02 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, C12N 15/81 (2006.01) C07K 14/47 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (21) International Application Number: KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, PCT/US20 15/049674 MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, (22) International Filing Date: PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, 11 September 2015 ( 11.09.201 5) SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of regional protection available): ARIPO (BW, GH, (30) Priority Data: GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, 62/050,045 12 September 2014 (12.09.2014) US TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, (71) Applicant: WHITEHEAD INSTITUTE FOR BIOMED¬ DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, ICAL RESEARCH [US/US]; Nine Cambridge Center, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, Cambridge, Massachusetts 02142-1479 (US).
    [Show full text]
  • Cycliny Protein Cycliny Protein
    Catalogue # Aliquot Size C87-30G-20 20 µg C87-30G-50 50 µg CyclinY Protein Recombinant protein expressed in Sf9 cells Catalog # C87-30G Lot # O797 -2 Product Description Purity Recombinant human CyclinY (2-end) was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. The gene accession number is NM_145012 . The purity of CyclinY was Gene Aliases determined to be >80% by densitometry. CCNY; C10orf9; CBCP1; CCNX; CFP1 Approx. MW 65kDa . Formulation Recombinant protein stored in 50mM Tris-HCl, pH 7.5, 50mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol. Storage and Stability Store product at –70 oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles. Scientific Background Cyclin Y belongs to the highly conserved cyclin family. The members of the cyclin family are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclin Y plays an important role in the processes of transcription, DNA repair, and cell cycle CyclinY Protein progression. Cyclin Y regulates cyclin-dependent kinases Recombinant protein expressed in Sf9 cells (1). Cyclin Y is an isoform of CCNY that is also known as Catalog Number C87-30G CFP1 variant A which has a calculated molecular mass of Specific Lot Number O797-2 36.9 kD. (2). Cyclin Y specifically activates transcription Purity >80% through the MYC promoter. Concentration 0.1 µ g/ µl Stability 1yr at –70 oC from date of shipment Storage & Shipping Store product at –70 oC.
    [Show full text]
  • Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
    Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ......................................................
    [Show full text]
  • Promoterless Transposon Mutagenesis Drives Solid Cancers Via Tumor Suppressor Inactivation
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.254565; this version posted August 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Promoterless Transposon Mutagenesis Drives Solid Cancers via Tumor Suppressor Inactivation 2 Aziz Aiderus1, Ana M. Contreras-Sandoval1, Amanda L. Meshey1, Justin Y. Newberg1,2, Jerrold M. Ward3, 3 Deborah Swing4, Neal G. Copeland2,3,4, Nancy A. Jenkins2,3,4, Karen M. Mann1,2,3,4,5,6,7, and Michael B. 4 Mann1,2,3,4,6,7,8,9 5 1Department of Molecular Oncology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA 6 2Cancer Research Program, Houston Methodist Research Institute, Houston, Texas, USA 7 3Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), 8 Singapore, Republic of Singapore 9 4Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, 10 Maryland, USA 11 5Departments of Gastrointestinal Oncology & Malignant Hematology, Moffitt Cancer Center & Research 12 Institute, Tampa, FL, USA 13 6Cancer Biology and Evolution Program, Moffitt Cancer Center & Research Institute, Tampa, FL, USA 14 7Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL, 15 USA. 16 8Donald A. Adam Melanoma and Skin Cancer Research Center of Excellence, Moffitt Cancer Center, Tampa, 17 FL, USA 18 9Department of Cutaneous Oncology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA 19 These authors contributed equally: Aziz Aiderus, Ana M.
    [Show full text]
  • Identification of Novel Regulatory Genes in Acetaminophen
    IDENTIFICATION OF NOVEL REGULATORY GENES IN ACETAMINOPHEN INDUCED HEPATOCYTE TOXICITY BY A GENOME-WIDE CRISPR/CAS9 SCREEN A THESIS IN Cell Biology and Biophysics and Bioinformatics Presented to the Faculty of the University of Missouri-Kansas City in partial fulfillment of the requirements for the degree DOCTOR OF PHILOSOPHY By KATHERINE ANNE SHORTT B.S, Indiana University, Bloomington, 2011 M.S, University of Missouri, Kansas City, 2014 Kansas City, Missouri 2018 © 2018 Katherine Shortt All Rights Reserved IDENTIFICATION OF NOVEL REGULATORY GENES IN ACETAMINOPHEN INDUCED HEPATOCYTE TOXICITY BY A GENOME-WIDE CRISPR/CAS9 SCREEN Katherine Anne Shortt, Candidate for the Doctor of Philosophy degree, University of Missouri-Kansas City, 2018 ABSTRACT Acetaminophen (APAP) is a commonly used analgesic responsible for over 56,000 overdose-related emergency room visits annually. A long asymptomatic period and limited treatment options result in a high rate of liver failure, generally resulting in either organ transplant or mortality. The underlying molecular mechanisms of injury are not well understood and effective therapy is limited. Identification of previously unknown genetic risk factors would provide new mechanistic insights and new therapeutic targets for APAP induced hepatocyte toxicity or liver injury. This study used a genome-wide CRISPR/Cas9 screen to evaluate genes that are protective against or cause susceptibility to APAP-induced liver injury. HuH7 human hepatocellular carcinoma cells containing CRISPR/Cas9 gene knockouts were treated with 15mM APAP for 30 minutes to 4 days. A gene expression profile was developed based on the 1) top screening hits, 2) overlap with gene expression data of APAP overdosed human patients, and 3) biological interpretation including assessment of known and suspected iii APAP-associated genes and their therapeutic potential, predicted affected biological pathways, and functionally validated candidate genes.
    [Show full text]
  • Enriched Genes FLX07
    enriched genes FLX07 Entrez Symbols Name TermID TermDesc 24950 MGC156498,S5AR 1,Srd5a1 steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) GO:0003865 3-oxo-5-alpha-steroid 4-dehydrogenase activity 361191 Nsun2,RGD1311954 NOL1/NOP2/Sun domain family, member 2 GO:0003865 3-oxo-5-alpha-steroid 4-dehydrogenase activity 305291 RGD1308828,S5AR 3,Srd5a3 steroid 5 alpha-reductase 3 GO:0003865 3-oxo-5-alpha-steroid 4-dehydrogenase activity 311569 Acas2,Acss2 acyl-CoA synthetase short-chain family member 2 GO:0003987 acetate-CoA ligase activity 296259 Acas2l,Acss1 acyl-CoA synthetase short-chain family member 1 GO:0003987 acetate-CoA ligase activity 25288 ACS,Acas,Acsl1,COAA,Facl2 acyl-CoA synthetase long-chain family member 1 GO:0003987 acetate-CoA ligase activity 114024 Acs3,Acsl3,Facl3 acyl-CoA synthetase long-chain family member 3 GO:0003987 acetate-CoA ligase activity 299002 G2e3,RGD1310263 G2/M-phase specific E3 ubiquitin ligase GO:0016881 acid-amino acid ligase activity 361866 Hace1 HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1 GO:0016881 acid-amino acid ligase activity 316395 Hecw2 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 GO:0016881 acid-amino acid ligase activity 309758 Herc4 hect domain and RLD 4 GO:0016881 acid-amino acid ligase activity 361815 MGC116114,Rnf8 ring finger protein 8 GO:0016881 acid-amino acid ligase activity 298576 Mul1,RGD1309944 mitochondrial ubiquitin ligase activator of NFKB 1 GO:0016881 acid-amino acid ligase activity
    [Show full text]
  • PDF Hosted at the Radboud Repository of the Radboud University Nijmegen
    PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/100868 Please be advised that this information was generated on 2017-12-06 and may be subject to change. Deciphering cellular responses to pathogens using genomics data Iziah Edwin Sama Deciphering cellular responses to pathogens using genomics data This research was performed at the Centre for Molecular and Biomolecular Informatics (CMBI), Nijmegen Centre of Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Funding: This work was supported by the VIRGO consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative and partially funded by the Dutch Government (BSIK 03012), The Netherlands. ISBN 978-90-9027062-3 © 2012 Iziah Edwin Sama All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, by print or otherwise, without permission in writing from the author Front Cover Image: A metaphorical illustration of the complexity in a host cell (the field), wherein fundamental moieties like proteins interact with each other (the network) in response to various pathogenic stimuli triggering respective cellular responses (the sub-fields demarcated by different line colors). The background is a picture of an indoors multi-sports field .The network is a protein-protein interaction network (HsapiensPPI of chapter 3) in which nodes represent proteins and edges between nodes indicate physical association. (Concept by Iziah Edwin Sama) Cover design and lay-out: In Zicht Grafisch Ontwerp, Arnhem Printed by: Ipskamp Drukkers, Enschede II Deciphering cellular responses to pathogens using genomics data Proefschrift ter verkrijging van de graad van doctor aan de Radboud Universiteit Nijmegen op gezag van de rector magnificus prof.
    [Show full text]
  • Rabbit Anti-Cyclin Y/FITC Conjugated Antibody-SL12060R-FITC
    SunLong Biotech Co.,LTD Tel: 0086-571- 56623320 Fax:0086-571- 56623318 E-mail:[email protected] www.sunlongbiotech.com Rabbit Anti-Cyclin Y/FITC Conjugated antibody SL12060R-FITC Product Name: Anti-Cyclin Y/FITC Chinese Name: FITC标记的周期素Y/X抗体 C10orf9; CBCP1; CCNX; CCNY; CFP1; Chromosome 10 open reading frame 9; Cyclin Alias: box carrying protein 1; Cyclin box protein 1; Cyclin fold protein 1; Cyclin X; Cyclin Y; CCNY_HUMAN. Organism Species: Rabbit Clonality: Polyclonal React Species: Human,Mouse,Rat,Chicken,Dog,Pig,Cow,Rabbit,Sheep, ICC=1:50-200IF=1:50-200 Applications: not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. Molecular weight: 39kDa Cellular localization: The cell membrane Form: Lyophilized or Liquid Concentration: 1mg/ml immunogen: KLH conjugated synthetic peptide derived from human Cyclin Y/Cyclin X Lsotype: IgG Purification: affinitywww.sunlongbiotech.com purified by Protein A Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year Storage: when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. background: Cyclin Y is a 341 amino acid protein belonging to the cyclin family. Cyclin Y exists as three alternatively spliced isoforms and contains a cyclin N-terminal domain. Cyclin Y Product Detail: may control cell division cycles and regulate cyclin-dependent kinases.
    [Show full text]